Evaluating anti-angiogenic therapy response in patients with GBM using Homodynamic Response Imaging

نویسندگان

  • D. Ben-Bashat
  • H. Ben-Ami
  • M. Artzi
  • D. Blumenthal
  • F. Bokstein
  • O. Aizenstein
  • Y. Edrei
  • B. Corn
چکیده

D. Ben-Bashat , H. Ben-Ami, M. Artzi, D. Blumenthal, F. Bokstein, O. Aizenstein, Y. Edrei, B. Corn, and R. Abramovitch The Wohl institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel, Neuro-Oncology Unit, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, Radiology Department, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel, Goldyne Savad Institute of Gene Therapy, Hadassah University Medical Center, Jerusalem, Israel, Institute of Radiotherapy, Tel Aviv Sourasky Medical Center, Tel-Aviv, Israel

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Pseudo-tumoral response of glioblastoma to anti-angiogenic treatment prematurely revealed by using Arterial spin-labeling (ASL) perfusion MRI and susceptibility weighted imaging (SWI)

Introduction: Angiogenesis plays a key-role in the growth and spread of solid tumors (1). This is especially true for Glioblastoma Multiforme (GBM), which is the most common and aggressive subtype of malignant glioma. New therapies involving anti-angiogenic agents may therefore now be part of the therapeutic protocol and they have been shown to dramatically improve response and survival in pati...

متن کامل

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials

This is an exciting time in neuro-oncology. Discoveries elucidating the molecular mechanisms of oncogenesis and the molecular subtypes of glioblastoma multiforme (GBM) have led to new diagnostic and classification schemes with more prognostic power than histology alone. Molecular profiling has become part of the standard neuropathological evaluation of GBM. Chemoradiation followed by adjuvant t...

متن کامل

Can Susceptibility-Weighted Imaging determine response to combined anti-angiogenic, cytotoxic, and radiation therapy in GBM patients?

J. M. Lupo, S. Cha, E. Essock-Burns, N. Butowski, and S. J. Nelson Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, United States, Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, United States, Department of Neurosurgery, University of California, San Francisco, San Fran...

متن کامل

18F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma

BACKGROUND Conflicting data exist for anti-cancer effects of anti-placental growth factor (anti-PlGF) in combination with anti-VEGF. Still, this treatment combination has not been evaluated in intracranial glioblastoma (GBM) xenografts. In clinical studies, position emission tomography (PET) using the radiolabeled amino acid O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) and magnetic resonance imag...

متن کامل

Neovascularization in Glioblastoma: Current Pitfall in Anti-angiogenic therapy.

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. However, the survival of patients with GBM has been dismal after multi-disciplinary treatment with surgery, radiotherapy, and chemotherapy. In the efforts to improve clinical outcome, anti-angiogenic therapy with bevacizumab (Avastin) was introduced to inhibit vascular endothelial growth factor (VEGF) mediated tumor ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2008